UK – SKYCovion COVID-19 vaccine authorised by MHRA

The new COVID-19 vaccine from SK Chemicals, has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.

SKYCovion, the COVID-19 vaccine developed by SK Chemicals, has today been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA).

It becomes the 8th COVID-19 vaccine authorised by the UK’s independent medicines regulator.

The authorisation follows advice received from the independent Commission on Human Medicines (CHM).

The SKYCovion vaccine combines a part of the SARS-CoV-2 virus spike protein with an ‘adjuvant’ – an additional ingredient designed to trigger a stronger immune response. It is given as two injections, four weeks part…